Role of combined oral contraceptives in women undergoing assisted reproduction treatment

2011 ◽  
Vol 6 (5) ◽  
pp. 495-499
Author(s):  
Shilpa Deb ◽  
Nicholas J Raine-Fenning
Keyword(s):  
Assisted Reproduction ◽  
Oral Contraceptives ◽  
Combined Oral Contraceptives ◽  
Assisted Reproduction Treatment

scholarly journals Anti-MüLlerian Hormone as a Marker of Ovarian Reserve: An Update

2008 ◽  
Vol 4 (2) ◽  
pp. 137-141 ◽  
Author(s):  
David M Robertson
Keyword(s):  
Assisted Reproduction ◽  
Ovarian Reserve ◽  
Ovarian Response ◽  
Müllerian Inhibiting Substance ◽  
Oocyte Yield ◽  
Reproductive Processes ◽  
Assisted Reproduction Treatment ◽  
Mullerian Inhibiting Substance

In recent years there has been an increasing interest in the role of anti-Müllerian hormone or Müllerian-inhibiting substance as a marker of ovarian reserve during assisted reproduction treatment and other reproductive processes. It is concluded that anti-Müllerian hormone is superior to other markers in predicting oocyte yield in IVF and appears useful in monitoring ovarian response in a range of reproductive states and disorders. This article reviews the literature published during 2006 and 2007.

Role of FSHR rs6165 and ESR2 rs4986938 polymorphisms in ovarian stimulation of Iranian women who underwent assisted reproduction treatment

2018 ◽  
Vol 26 (3) ◽  
pp. 121-126 ◽  
Author(s):  
Maryam Kaviani ◽  
Sayyed Mohammad Hossein Ghaderian ◽  
Soheila Arefi ◽  
Mehrdad Hashemi ◽  
Sarah Sadat Aghabozorg Afjeh
Keyword(s):  
Assisted Reproduction ◽  
Ovarian Stimulation ◽  
Iranian Women ◽  
Assisted Reproduction Treatment ◽  
Stimulation Of

Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes

2010 ◽  
Vol 94 (7) ◽  
pp. 2796-2799 ◽  
Author(s):  
Dominique de Ziegler ◽  
Vanessa Gayet ◽  
François Xavier Aubriot ◽  
Patricia Fauque ◽  
Isabelle Streuli ◽  
...  
Keyword(s):  
Assisted Reproduction ◽  
Oral Contraceptives ◽  
Assisted Reproduction Treatment

Platelet Adhesiveness in Symptomatic Women Taking Oral Contraceptives

1971 ◽  
Vol 26 (03) ◽  
pp. 426-430 ◽  
Author(s):  
T. F Zuck ◽  
J. J Bergin ◽  
Jane M. Raymond ◽  
W. R Dwyre ◽  
D. G Corby
Keyword(s):  
Oral Contraceptives ◽  
Platelet Adhesiveness ◽  
Combined Oral Contraceptives ◽  
Increased Risk ◽  
Normal Women ◽  
Asymptomatic Women

SummaryPlatelet adhesiveness to glass was determined in several groups of women. Increases were found in women developing thrombovascular symptoms while taking combined oral contraceptives, compared to both normal women and asymptomatic users of oral contraceptives. Despite this increase, overlap of the groups did not permit discrimination between symptomatic and asymptomatic women. However, it is possible, that in concert with other coagulation changes, platelet adhesiveness to glass may prove adjunctive in defining women at increased risk of developing thrombovascular symptoms while taking oral contraceptives, and further define the mechanism of the increased risk.

Sign in / Sign up

Export Citation Format

Share Document